Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Non-Current Deferred Tax Liability: 2010-2024

Historic Non-Current Deferred Tax Liability for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $731,202.

  • China Pharma Holdings' Non-Current Deferred Tax Liability fell 1.38% to $739,733 in Q3 2025 from the same period last year, while for Sep 2025 it was $739,733, marking a year-over-year decrease of 1.38%. This contributed to the annual value of $731,202 for FY2024, which is 1.47% down from last year.
  • Latest data reveals that China Pharma Holdings reported Non-Current Deferred Tax Liability of $731,202 as of FY2024, which was down 1.47% from $742,114 recorded in FY2023.
  • China Pharma Holdings' Non-Current Deferred Tax Liability's 5-year high stood at $824,407 during FY2021, with a 5-year trough of $731,202 in FY2024.
  • In the last 3 years, China Pharma Holdings' Non-Current Deferred Tax Liability had a median value of $742,114 in 2023 and averaged $742,671.
  • As far as peak fluctuations go, China Pharma Holdings' Non-Current Deferred Tax Liability grew by 6.92% in 2020, and later dropped by 8.46% in 2022.
  • Yearly analysis of 5 years shows China Pharma Holdings' Non-Current Deferred Tax Liability stood at $805,556 in 2020, then grew by 2.34% to $824,407 in 2021, then dropped by 8.46% to $754,698 in 2022, then dropped by 1.67% to $742,114 in 2023, then fell by 1.47% to $731,202 in 2024.